Clinical Trial Update: Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension [Phase 1]

View source ↗

Summary

Phase 1 single-dose study evaluating Atovaquone/Proguanil hydrochloride combination tablets and Atovaquone suspension for malaria; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Atovaquone suspension (Atovaquone)
• Atovaquone/proguanil hydrochloride combination tablets (Atovaquone and Proguanil hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 1 | Status: COMPLETED